Skip to main content
INVA logo
INVA
(NASDAQ)
Innoviva, Inc.
$22.99-- (--)
Loading... - Market loading

Innoviva (INVA) Stock Price & Financial Analysis

Innoviva Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.91 - $23.37
52-Week High$25.15
52-Week Low$16.52
Open$23.21
Volume595.08K
Average Volume (3M)595.08K
Market Cap1.96B
Shares Outstanding85.26M
P/E Ratio (TTM)7.36
Forward P/E3.68
Price to Sales (P/S)4.81
Price to Book (P/B)1.70
EV/EBITDA4.59
Revenue (TTM)414.76M
Net Income (TTM)271.17M
Free Cash Flow (TTM)194.68M
EPS (TTM)$3.18
Profit Margin65.38%
Operating Margin39.48%
Return on Equity (ROE)23.12%
Debt to Equity0.23
50-Day MA$22.04
200-Day MA$20.22
52-Week Change30.49%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateSep 8, 2015

Frequently Asked Questions About Innoviva

What is the current stock price for INVA?

As of the latest trading session, INVA stock trades at $22.99. The 52-week range is $16.52–$25.15, with a day range of $22.91–$23.37.

What is the P/E ratio for INVA?

Innoviva's trailing P/E ratio is 7.4, meaning investors pay $7.4 for every $1 of annual earnings. The forward P/E is 3.7, reflecting analyst expectations for future earnings. Innoviva operates in the Healthcare sector.

Does INVA pay dividends?

Innoviva does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for INVA?

Based on 1 analyst, the consensus for INVA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of INVA?

Innoviva's market capitalization is $1.96B, classifying it as a small-cap company. Innoviva operates in the Healthcare sector within the Biotechnology industry.